Rare diseases
Investigational molecules
Locations
Back to Greece1 008 clinical trials in Chaidari, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Phase 3 Study of Mitapivat to Reduce Transfusions in Children with Alpha or Beta Transfusion‑Dependent Thalassemia
GreeceEvaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis
GreeceRandomized study of ketotifen nasal spray (0.025% and 0.050%) versus sodium cromoglicate nasal spray in patients with rhinitis
GreecePhase 2 Study of RADAMTS13 in Adults with Acute Ischemic Stroke
GreeceLong‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
GreeceClarithromycin to prevent secondary infections in adult patients with community-acquired pneumonia-related sepsis
GreeceLong‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis
GreeceA study to evaluate the use of meropenem to reduce the risk of sepsis in patients with suspected infection in the emergency department
GreeceA study to compare REGN7508 and acetylsalicylic acid for preventing blood clots in adults undergoing elective total knee replacement.
GreeceA study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis
GreeceA Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma
GreeceStudy of Drug Combination with Amodiaquine and Potassium Canrenoate Plus Exenatide or Glibenclamide for Patients with Acute Ischemic Stroke
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on squamous cell carcinoma of the head and neck, exploring combination therapy approaches that integrate immunotherapy with traditional treatments.
The study evaluates the effectiveness of combining nivolumab with standard cisplatin-radiotherapy, aiming to improve disease-free survival rates in patients with resected head and neck cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
